- Home
- CNVS vs TENX Comparison
CNVS vs TENX Comparison
Compare CNVS & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNVS | TENX |
|---|---|---|
| Founded | 2000 | 1967 |
| Country | United States | United States |
| Employees | 218 | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 56.2M |
| IPO Year | 2016 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CNVS | TENX |
|---|---|---|
| Price | $2.64 | $11.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $29.67 |
| AVG Volume (30 Days) | 146.2K | ★ 588.5K |
| Earning Date | 02-17-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $78,181,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $84.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 59.13 | N/A |
| 52 Week Low | $1.77 | $5.34 |
| 52 Week High | $7.39 | $18.38 |
Technical Indicators
Market Signals| Indicator | CNVS | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 58.57 | 36.55 |
| Support Level | $2.31 | $10.83 |
| Resistance Level | $3.47 | $14.15 |
| Average True Range (ATR) | 0.15 | 0.98 |
| MACD | 0.03 | -0.28 |
| Stochastic Oscillator | 79.57 | 4.99 |
Price Performance
Historical ComparisonAbout CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.